SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?


To: jerryf who wrote (4541)4/5/1998 3:42:00 PM
From: LouieD  Read Replies (5) | Respond to of 34592
 
To All:...Please Read

I live in Philly and just read an article in The Inquire about the drug tamoxifen.It's made by a pharmaceutical company named Zeneca.They just release the results of a study by the National Cancer Institute that showed tamoxifen reduced the rate of breast cancer in women by 45%.The new release won't be out till wednsday.The Inquire got the story because Zeneca <ZEN> mailed out the results to 13,000 women who participated in then trials.Also the stock's trading at 137 a share and could split very soon.Any comments are appreciated.

LouieD